High expression of serine protease inhibitor 7 (SERPINB7) is associated with unfavorable overall survival of patients with cervical cancer [39], as well as patients with pancreatic cancer [40] and NSCLC patients receiving a standard care, including chemotherapy [41]. This evidence concerns the gene SERPINB7 and pancreatic neoplasm.